DNMT3A and acute myeloid leukemia: Thus, while the inferior prognosis of AML with NPM1, DNMT3A, and FLT3-ITD is likely to be related to its over-representation in NPM1class II, this genotype in itself is not a suitable surrogate marker for NPM1class II.